Open AccessJournal Article
Establishment and characterization of a human prostatic carcinoma cell line (PC-3).
TLDR
The establishment, characterization, and tumorigenicity of a new epithelial cell line (PC-3) from a human prostatic adenocarcinoma metastatic to bone is reported, which should be useful in investigating the biochemical changes in advanced prostatic cancer cells and in assessing their response to chemotherapeutic agents.Abstract:
The establishment, characterization, and tumorigenicity of a new epithelial cell line (PC-3) from a human prostatic adenocarcinoma metastatic to bone is reported The cultured cells show anchorage-independent growth in both monolayers and in soft agar suspension and produce subcutaneous tumors in nude mice Culture of the transplanted tumor yielded a human cell line with characteristics identical to those used initially to produce the tumor PC-3 has a greatly reduced dependence upon serum for growth when compared to normal prostatic epithelial cells and does not respond to androgens, glucocorticoids, or epidermal or fibroblast gowth factors Karyotypic analysis by quinacrine banding revealed the cells to be completely aneuploid with a modal chromosome number in the hypotriploid range At least 10 distinctive marker chromosomes were identified The overall karyotype as well as the marker chromosomes are distinct from those of the HeLa cell Electron microscopic studies revealed many features common to neoplastic cells of epithelial origin including numerous microvilli, junctional complexes, abnormal nuclei and nucleoli, abnormal mitochondria, annulate lamellae, and lipoidal bodies Overall, the functional and morphologic characteristics of PC-3 are those of a poorly-differentiated adenocarcinoma These cells should be useful in investigating the biochemical changes in advanced prostatic cancer cells and in assessing their response to chemotherapeutic agentsread more
Citations
More filters
Journal ArticleDOI
Evaluating Baculovirus as a Vector for Human Prostate Cancer Gene Therapy
Stephanie L. Swift,Guillermo C. Rivera,Vincent Dussupt,Regina M. Leadley,Lucy C. Hudson,Corrina M.A. de Ridder,Robert Kraaij,Julie E. Burns,Norman J. Maitland,Lindsay J. Georgopoulos +9 more
TL;DR: BV is capable of transducing a large proportion of prostate cell types within a heterogeneous 3-D prostate tumour, can facilitate cell death using a pro-drug approach, and shows promise as a vector for the treatment of prostate cancer.
Journal ArticleDOI
Comparison of level of NKG2D ligands between normal and tumor tissue using multiplex RT-PCR.
S.Y. Park,Jae-Ho Bae,Sang-Doo Kim,Young-Ok Son,Joo Young Kim,Hyun Jin Park,Chang Hun Lee,Do-Youn Park,Jee-Yeon Kim,Min-Ki Lee,Byung-Seon Chung,Sun-Hee Kim,Chi-Dug Kang +12 more
TL;DR: The results demonstrated that the multiplex RT-PCR might be a useful diagnostics to detect the expression levels ofNKG2D ligands in tissues as well as cells, and suggested that the gastrointestinal tumors might be good candidates for NK cell-based cancer immunotherapy, since it showed significantly higher levels of NKG2d ligands than adjacent normal tissues.
Journal ArticleDOI
Increased potency of the PHSCN dendrimer as an inhibitor of human prostate cancer cell invasion, extravasation, and lung colony formation
TL;DR: Since many patients newly diagnosed with prostate cancer already have locally advanced or metastatic disease, the availability of a well-tolerated, nontoxic systemic therapy, like the PHSCN dendrimer, which prevents metastatic progression by inhibiting invasion, could be very beneficial.
Journal ArticleDOI
Annomocherin, annonacin and annomontacin: a novel and two known bioactive mono-tetrahydrofuran annonaceous acetogenins from Annona cherimolia seeds.
TL;DR: A novel and two known bioactive mono-tetrahydrofuran (THF) annonaceous acetogenins, annomocherin and annonacin, have been isolated from the fractionated ethanolic extracts of the seeds of Annona cherimolia, guided by the brine shrimp lethality test (BST).
Journal ArticleDOI
Development of a high affinity Anticalin® directed against human CD98hc for theranostic applications.
Friedrich-Christian Deuschle,Volker Morath,André Schiefner,Corinna Brandt,S. Ballke,Sybille Reder,Katja Steiger,Markus Schwaiger,Wolfgang A. Weber,Arne Skerra +9 more
TL;DR: In vitro studies revealed specific binding activity of the Anticalin towards various CD98hc-expressing human tumor cell lines, suggesting broader applicability in cancer research, and provides a first proof of concept to exploit CD 98hc for non-invasive biomedical imaging.